Search research articles
Contact Us
Filters
Showing results (411-420 of 455) with videos related to
Page
of 46
Sort By:
Annals of Surgical Oncology
|
September 25, 2016
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial
Irene L Wapnir, Shari Gelber, Stewart J Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Plos One
|
July 15, 2011
Transcriptome sequencing, and rapid development and application of SNP markers for the legume pod borer Maruca vitrata (Lepidoptera: Crambidae)
Venu M Margam, Brad S Coates, Darrell O Bayles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2007
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
Alan S Coates, Aparna Keshaviah, Beat Thürlimann, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial
Meredith M Regan, Brian Leyland-Jones, Mark Bouzyk, et al.
Insect Molecular Biology
|
November 15, 2015
Quantitative trait locus mapping and functional genomics of an organophosphate resistance trait in the western corn rootworm, Diabrotica virgifera virgifera
B S Coates, A P Alves, H Wang, et al.
Cancer
|
December 8, 2020
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial
Jose P Leone, Bernard F Cole, Meredith M Regan, et al.
The Lancet. Oncology
|
June 21, 2015
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
Jürg Bernhard, Weixiu Luo, Karin Ribi, et al.
Cancer
|
March 26, 2003
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V
Vito J Spataro, Heather Litman, Giuseppe Viale, et al.
Page
of 46
Search research articles
Search
Showing results (411-420 of 455) with videos related to
Sort By:
Page
of 46
Annals of Surgical Oncology
|
September 25, 2016
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial
Irene L Wapnir, Shari Gelber, Stewart J Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
G Berclaz, S Li, K N Price, et al.
Plos One
|
July 15, 2011
Transcriptome sequencing, and rapid development and application of SNP markers for the legume pod borer Maruca vitrata (Lepidoptera: Crambidae)
Venu M Margam, Brad S Coates, Darrell O Bayles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII
D Crivellari, M Bonetti, M Castiglione-Gertsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2007
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
Alan S Coates, Aparna Keshaviah, Beat Thürlimann, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial
Meredith M Regan, Brian Leyland-Jones, Mark Bouzyk, et al.
Insect Molecular Biology
|
November 15, 2015
Quantitative trait locus mapping and functional genomics of an organophosphate resistance trait in the western corn rootworm, Diabrotica virgifera virgifera
B S Coates, A P Alves, H Wang, et al.
Cancer
|
December 8, 2020
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial
Jose P Leone, Bernard F Cole, Meredith M Regan, et al.
The Lancet. Oncology
|
June 21, 2015
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials
Jürg Bernhard, Weixiu Luo, Karin Ribi, et al.
Cancer
|
March 26, 2003
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V
Vito J Spataro, Heather Litman, Giuseppe Viale, et al.
Page
of 46